Efficacy of ethinylestradiol 20 µg/drospirenone 3 mg in a flexible extended regimen in women with moderate-to-severe primary dysmenorrhoea: an open-label, multicentre, randomised, controlled study

OBJECTIVES: The aim of this Phase III, multicentre, open-label, randomised study was to compare the efficacy and safety of ethinylestradiol (EE)/drospirenone (DRSP) in a new flexible extended regimen that allowed the management of intracyclic (breakthrough) bleeding (MIB) with that of EE/DRSP in a c...

Full description

Saved in:
Bibliographic Details
Main Authors: Strowitzki, Thomas, Kirsch, Bodo, Elliesen, Jörg
Format: Artigo
Language:Inglês
Published: BMJ Group 2012
Subjects:
Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3353877/
https://ncbi.nlm.nih.gov/pubmed/22454006
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jfprhc-2011-100225
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items